PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 3-year regional lipid clinic experience. (August 2021)

Record Type:: Journal Article
Title:: PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 3-year regional lipid clinic experience. (August 2021)
Main Title:: PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 3-year regional lipid clinic experience
Authors:: Anastasiou, G.
Liamis, G.
Milionis, H.
Elisaf, M.
Christopoulou, E.
Dimitriou, T.
Liberopoulos, E.N.
Abstract:
Is Part Of:: Atherosclerosis. Volume 331(2021)
Journal:: Atherosclerosis
Issue:: Volume 331(2021)
Issue Display:: Volume 331, Issue 2021 (2021)
Year:: 2021
Volume:: 331
Issue:: 2021
Issue Sort Value:: 2021-0331-2021-0000
Page Start:: e134
Page End:
Publication Date:: 2021-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2021.06.399 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21763.xml